Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	negative regulation of cyclin-dependent protein serine/threonine kinase activity	HEXIM1 HEXIM2 LATS1 LATS2	1.37e-05	29	105	4	GO:0045736
GeneOntologyBiologicalProcess	negative regulation of cyclin-dependent protein kinase activity	HEXIM1 HEXIM2 LATS1 LATS2	1.57e-05	30	105	4	GO:1904030
GeneOntologyBiologicalProcess	inner cell mass cell fate commitment	LATS1 LATS2	7.68e-05	3	105	2	GO:0001827
GeneOntologyBiologicalProcess	inner cell mass cellular morphogenesis	LATS1 LATS2	7.68e-05	3	105	2	GO:0001828
Domain	HEXIM	HEXIM1 HEXIM2	3.07e-05	2	104	2	IPR024872
Domain	HEXIM	HEXIM1 HEXIM2	3.07e-05	2	104	2	PF15313
Domain	Glyco_hydro_15	PHKA1 PHKB	9.18e-05	3	104	2	PF00723
Domain	Glyco_hydro_15/PHK	PHKA1 PHKB	9.18e-05	3	104	2	IPR011613
Domain	PHK_A/B_su	PHKA1 PHKB	9.18e-05	3	104	2	IPR008734
Domain	MABP	DENND4A MVB12B	1.83e-04	4	104	2	IPR023341
Domain	MABP	DENND4A MVB12B	1.83e-04	4	104	2	PS51498
Domain	DUF4704	NBEAL1 WDFY3	3.04e-04	5	104	2	IPR031570
Domain	DUF4704	NBEAL1 WDFY3	3.04e-04	5	104	2	PF15787
Domain	Na_trans_cytopl	SCN1A SCN9A	4.54e-04	6	104	2	PF11933
Domain	PH_BEACH	NBEAL1 WDFY3	4.54e-04	6	104	2	PF14844
Domain	Na_trans_cytopl	SCN1A SCN9A	4.54e-04	6	104	2	IPR024583
Domain	IQ	SCN1A MYO1F SCN9A CAMTA1	6.62e-04	71	104	4	PF00612
Domain	PH-BEACH_dom	NBEAL1 WDFY3	8.41e-04	8	104	2	IPR023362
Domain	-	NBEAL1 WDFY3	8.41e-04	8	104	2	2.30.29.40
Domain	DHC_N1	DNAH10 DNAH2	8.41e-04	8	104	2	PF08385
Domain	PH_BEACH	NBEAL1 WDFY3	8.41e-04	8	104	2	PS51783
Domain	Dynein_heavy_dom-1	DNAH10 DNAH2	8.41e-04	8	104	2	IPR013594
Domain	UBA	UBAP2 LATS1 LATS2	1.05e-03	36	104	3	PF00627
Domain	BEACH_dom	NBEAL1 WDFY3	1.08e-03	9	104	2	IPR000409
Domain	BEACH	NBEAL1 WDFY3	1.08e-03	9	104	2	PS50197
Domain	Beach	NBEAL1 WDFY3	1.08e-03	9	104	2	PF02138
Domain	-	NBEAL1 WDFY3	1.08e-03	9	104	2	1.10.1540.10
Domain	Beach	NBEAL1 WDFY3	1.08e-03	9	104	2	SM01026
Domain	IQ	SCN1A MYO1F SCN9A CAMTA1	1.09e-03	81	104	4	SM00015
Domain	Na_channel_asu	SCN1A SCN9A	1.34e-03	10	104	2	IPR001696
Domain	Na_trans_assoc	SCN1A SCN9A	1.34e-03	10	104	2	IPR010526
Domain	Na_trans_assoc	SCN1A SCN9A	1.34e-03	10	104	2	PF06512
Domain	IQ_motif_EF-hand-BS	SCN1A MYO1F SCN9A CAMTA1	1.61e-03	90	104	4	IPR000048
Domain	IQ	SCN1A MYO1F SCN9A CAMTA1	1.81e-03	93	104	4	PS50096
Domain	UBA	UBAP2 LATS1 LATS2	1.88e-03	44	104	3	IPR015940
Domain	UBA	UBAP2 LATS1 LATS2	2.28e-03	47	104	3	PS50030
Domain	6-hairpin_glycosidase-like	PHKA1 PHKB	2.30e-03	13	104	2	IPR008928
Domain	Dynein_heavy_chain_D4_dom	DNAH10 DNAH2	2.68e-03	14	104	2	IPR024317
Domain	Dynein_HC_stalk	DNAH10 DNAH2	2.68e-03	14	104	2	IPR024743
Domain	Myotubularin-like_Pase_dom	MTMR8 MTMR7	2.68e-03	14	104	2	IPR010569
Domain	Dynein_heavy_dom-2	DNAH10 DNAH2	2.68e-03	14	104	2	IPR013602
Domain	DHC_N2	DNAH10 DNAH2	2.68e-03	14	104	2	PF08393
Domain	MT	DNAH10 DNAH2	2.68e-03	14	104	2	PF12777
Domain	AAA_8	DNAH10 DNAH2	2.68e-03	14	104	2	PF12780
Domain	PPASE_MYOTUBULARIN	MTMR8 MTMR7	2.68e-03	14	104	2	PS51339
Domain	ATPase_dyneun-rel_AAA	DNAH10 DNAH2	2.68e-03	14	104	2	IPR011704
Domain	Myotubularin_fam	MTMR8 MTMR7	2.68e-03	14	104	2	IPR030564
Domain	Myotub-related	MTMR8 MTMR7	2.68e-03	14	104	2	PF06602
Domain	AAA_5	DNAH10 DNAH2	2.68e-03	14	104	2	PF07728
Domain	DHC_fam	DNAH10 DNAH2	3.08e-03	15	104	2	IPR026983
Domain	Dynein_heavy_dom	DNAH10 DNAH2	3.08e-03	15	104	2	IPR004273
Domain	Dynein_heavy	DNAH10 DNAH2	3.08e-03	15	104	2	PF03028
Domain	AGC-kinase_C	LATS1 LATS2 MASTL	3.75e-03	56	104	3	IPR000961
Domain	AGC_KINASE_CTER	LATS1 LATS2 MASTL	3.75e-03	56	104	3	PS51285
Domain	S_TK_X	LATS1 LATS2 MASTL	3.75e-03	56	104	3	SM00133
Domain	-	SEMA3G PKHD1L1 LILRB1 KIRREL3 LRFN5 ATF7IP CAMTA1 SDK1 PALLD CD96	3.87e-03	663	104	10	2.60.40.10
Domain	Channel_four-helix_dom	TPTE2 SCN1A SCN9A	3.95e-03	57	104	3	IPR027359
Domain	-	TPTE2 SCN1A SCN9A	3.95e-03	57	104	3	1.20.120.350
Domain	UBA-like	UBAP2 LATS1 LATS2	5.46e-03	64	104	3	IPR009060
Pubmed	Human transcription factor protein interaction networks.	NCOA2 TET2 UBAP2 ERG COPA DNAH10 SEC24A ETV3 LARP1 C15orf39 DARS1 ZHX2 ANKHD1 HEXIM2 HMG20A ARID1B PRRC2C ATF7IP ANKRD17 UNK SUFU	2.70e-09	1429	108	21	35140242
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	NCOA2 ABCF3 COPA WDR70 LARP1 DARS1 ECPAS ANKHD1 HEXIM2 TTLL7 CRACD PRRC2C MAPKAPK3 ANKRD17 SUFU TOP3B	9.91e-09	857	108	16	25609649
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	COPA LARP1 MED1 ECPAS PHKB MSH6 PRRC2C ANKRD17 TOP3B	1.50e-08	202	108	9	33005030
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	UBAP2 DSG1 TCOF1 DLGAP5 WDR70 LARP1 DARS1 MED1 ANKHD1 CRACD MSH6 PRRC2C ATF7IP MASTL ANKRD17 PALLD	3.27e-08	934	108	16	33916271
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	UBAP2 ABCF3 HYOU1 COPA DSG1 LARP1 DARS1 MED1 ANKHD1 PRRC2C ANKRD17 UNK TOP3B PALLD	5.84e-08	724	108	14	36232890
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ERG COPA TCOF1 NELFA DLGAP5 LARP1 MED1 ECPAS TERF2IP HEXIM2 MSH6 LATS1 ANKRD17 UNK	1.32e-07	774	108	14	15302935
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	HYOU1 TCOF1 SPRR3 TPTE2 WDR70 MTMR8 GRB2 ECPAS ANKHD1 ABRAXAS2 TXNL1 MSH6 MTMR7 ANKRD17 SUFU	3.56e-07	974	108	15	28675297
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	DNAH10 TPTE2 MTMR8 DNAH2 GRB2 BIRC2 SEMA3G MTMR7 ARID1B TTBK1 LATS1 LATS2 MMP8	4.56e-07	730	108	13	34857952
Pubmed	WWP2 ubiquitylates RNA polymerase II for DNA-PK-dependent transcription arrest and repair at DNA breaks.	UBAP2 TCOF1 NELFA GRB2 LARP1 DARS1 HEXIM1 ABRAXAS2 ARID1B PRRC2C ANKRD17 PALLD	5.01e-07	615	108	12	31048545
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TET2 UBAP2 DLGAP5 SERTAD2 LARP1 SPIRE1 ECPAS ANKHD1 ARID1B ANKRD17 UNK	8.31e-07	529	108	11	14621295
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	HYOU1 COPA SEC24A TPTE2 MTMR8 GRB2 C2CD4C ABRAXAS2 PHKA1 PHKB MSH6 MTMR7 ARID1B SUFU TOP3B	9.01e-07	1049	108	15	27880917
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	NCOA2 UBAP2 TCOF1 LARP1 MED1 ANKHD1 MSH6 ARID1B LATS1 PRRC2C PALLD	1.19e-06	549	108	11	38280479
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	NCOA2 VPS37A ABCF3 NELFA WDR70 LARP1 MED1 ZHX2 MASTL PALLD	1.32e-06	444	108	10	34795231
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	NCOA2 TET2 HYOU1 NELFA GRB2 LARP1 C15orf39 DARS1 MED1 ECPAS HEXIM1 TXNL1 MSH6 ARID1B PRRC2C	1.68e-06	1103	108	15	34189442
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	NCOA2 TET2 NELFA ETV3 MED1 HEXIM1 TXNL1 ARID1B	2.03e-06	268	108	8	33640491
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	HYOU1 COPA TCOF1 SEC24A LARP1 DARS1 ECPAS TXNL1 LATS1 PRRC2C ANKRD17 PALLD	2.17e-06	708	108	12	39231216
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	NCOA2 ZNF793 VPS37A SLC31A1 WDR70 LARP1 SPIRE1 ECPAS ZHX2 TERF2IP HEXIM2 PHKB UBE2J2 LATS2 ANKRD17 PLA2G6 CAMTA1	3.42e-06	1489	108	17	28611215
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	COPA TCOF1 NELFA DLGAP5 LARP1 MED1 TERF2IP MSH6 MASTL PALLD	4.00e-06	503	108	10	16964243
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	NCOA2 TET2 GRB2 LARP1 C15orf39 ZHX2 ARID1B ATF7IP SUFU	4.44e-06	398	108	9	35016035
Pubmed	Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.	UBAP2 TCOF1 GRB2 LARP1 MED1 ZHX2 TERF2IP PRRC2C PALLD	4.53e-06	399	108	9	35987950
Pubmed	BioID Performed on Golgi Enriched Fractions Identify C10orf76 as a GBF1 Binding Protein Essential for Golgi Maintenance and Secretion.	UBAP2 ABCF3 LARP1 ECPAS TXNL1 PRRC2C ANKRD17	5.30e-06	216	108	7	31519766
Pubmed	Proteomic and Interactome Approaches Reveal PAK4, PHB-2, and 14-3-3η as Targets of Overactivated Cdc42 in Cellular Responses to Genomic Instability.	HYOU1 COPA DSG1 GRB2 TXNL1 MASTL PALLD	6.92e-06	225	108	7	31478661
Pubmed	Inhibition of Tat activity by the HEXIM1 protein.	HEXIM1 HEXIM2	9.55e-06	2	108	2	15992410
Pubmed	Association analysis between SNPs in LATS1 and LATS2 and non-cardia gastric cancer.	LATS1 LATS2	9.55e-06	2	108	2	32423384
Pubmed	Deletion of Lats1/2 in adult kidney epithelia leads to renal cell carcinoma.	LATS1 LATS2	9.55e-06	2	108	2	34060480
Pubmed	Mutation analysis of large tumor suppressor genes LATS1 and LATS2 supports a tumor suppressor role in human cancer.	LATS1 LATS2	9.55e-06	2	108	2	25482410
Pubmed	Lats1/2-Mediated Alteration of Hippo Signaling Pathway Regulates the Fate of Bone Marrow-Derived Mesenchymal Stem Cells.	LATS1 LATS2	9.55e-06	2	108	2	30671453
Pubmed	Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma.	LATS1 LATS2	9.55e-06	2	108	2	17049657
Pubmed	Lats1 and Lats2 are required for ovarian granulosa cell fate maintenance.	LATS1 LATS2	9.55e-06	2	108	2	31268774
Pubmed	Isoform diversity of phosphorylase kinase alpha and beta subunits generated by alternative RNA splicing.	PHKA1 PHKB	9.55e-06	2	108	2	1874721
Pubmed	Rapid P-TEFb-dependent transcriptional reorganization underpins the glioma adaptive response to radiotherapy.	HEXIM1 HEXIM2	9.55e-06	2	108	2	38816355
Pubmed	A single copy of large tumor suppressor 1 or large tumor suppressor 2 is sufficient for normal hematopoiesis.	LATS1 LATS2	9.55e-06	2	108	2	32826458
Pubmed	AICAR Antiproliferative Properties Involve the AMPK-Independent Activation of the Tumor Suppressors LATS 1 and 2.	LATS1 LATS2	9.55e-06	2	108	2	29730476
Pubmed	The Hippo pathway regulates human megakaryocytic differentiation.	LATS1 LATS2	9.55e-06	2	108	2	27786336
Pubmed	N-terminal truncation of Lats1 causes abnormal cell growth control and chromosomal instability.	LATS1 LATS2	9.55e-06	2	108	2	23230145
Pubmed	TET2 and LILRB1 mutations are frequent in Epstein-Barr virus-positive diffuse large B-cell lymphoma especially in elderly patients.	TET2 LILRB1	9.55e-06	2	108	2	36812290
Pubmed	Indeterminate Dendritic Cell Tumor: A Report of Two New Cases Lacking the ETV3-NCOA2 Translocation and a Literature Review.	NCOA2 ETV3	9.55e-06	2	108	2	29877893
Pubmed	Cell type-dependent function of LATS1/2 in cancer cell growth.	LATS1 LATS2	9.55e-06	2	108	2	30531839
Pubmed	Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers.	LATS1 LATS2	9.55e-06	2	108	2	15746036
Pubmed	Natural killer cell profiles in recurrent pregnancy loss: Increased expression and positive associations with TACTILE and LILRB1.	LILRB1 CD96	9.55e-06	2	108	2	36004818
Pubmed	Identification of LATS transcriptional targets in HeLa cells using whole human genome oligonucleotide microarray.	LATS1 LATS2	9.55e-06	2	108	2	19799973
Pubmed	LATS1 but not LATS2 represses autophagy by a kinase-independent scaffold function.	LATS1 LATS2	9.55e-06	2	108	2	31848340
Pubmed	Expression of LATS family proteins in ovarian tumors and its significance.	LATS1 LATS2	9.55e-06	2	108	2	25841306
Pubmed	LATS suppresses mTORC1 activity to directly coordinate Hippo and mTORC1 pathways in growth control.	LATS1 LATS2	9.55e-06	2	108	2	32015438
Pubmed	A novel immuno-competitive capture mass spectrometry strategy for protein-protein interaction profiling reveals that LATS kinases regulate HCV replication through NS5A phosphorylation.	LATS1 LATS2	9.55e-06	2	108	2	25044019
Pubmed	Evidence for a tumor suppressor role for the large tumor suppressor genes LATS1 and LATS2 in human cancer.	LATS1 LATS2	9.55e-06	2	108	2	24026096
Pubmed	The transcription-dependent dissociation of P-TEFb-HEXIM1-7SK RNA relies upon formation of hnRNP-7SK RNA complexes.	HEXIM1 HEXIM2	9.55e-06	2	108	2	17709395
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	DENND4A NELFA LARP1 ECPAS ABRAXAS2 ARID1B LATS1 LATS2 UNK	1.10e-05	446	108	9	24255178
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	NCOA2 SEC24A WDR70 ANKHD1 NDUFB4 TXNL1 ARID1B PRRC2C ANKRD17	1.34e-05	457	108	9	32344865
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	UBAP2 TCOF1 DLGAP5 LARP1 TXNL1 PRRC2C ANKRD17	1.60e-05	256	108	7	33397691
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	COPA DSG1 WDR70 PHKA1 PHKB PRRC2C SCN9A UNK TOP3B	1.82e-05	475	108	9	31040226
Pubmed	Genome-Wide CRISPR-Cas9 Screens Expose Genetic Vulnerabilities and Mechanisms of Temozolomide Sensitivity in Glioblastoma Stem Cells.	UBAP2 ANKHD1 PRRC2C ANKRD17 TOP3B	2.17e-05	107	108	5	30995489
Pubmed	Lost in transcription: molecular mechanisms that control HIV latency.	NELFA HEXIM1 HEXIM2	2.72e-05	19	108	3	23518577
Pubmed	TDP-43 enhances translation of specific mRNAs linked to neurodegenerative disease.	DENND4A CAMTA1	2.86e-05	3	108	2	30357366
Pubmed	A FUS-LATS1/2 Axis Inhibits Hepatocellular Carcinoma Progression via Activating Hippo Pathway.	LATS1 LATS2	2.86e-05	3	108	2	30308519
Pubmed	[Misregulation of P-TEFb activity: pathological consequences].	HEXIM1 HEXIM2	2.86e-05	3	108	2	22377309
Pubmed	Coactivators for the orphan nuclear receptor RORalpha.	NCOA2 MED1	2.86e-05	3	108	2	10478845
Pubmed	Mutations in the sodium channel genes SCN1A, SCN3A, and SCN9A in children with epilepsy with febrile seizures plus(EFS+).	SCN1A SCN9A	2.86e-05	3	108	2	33895391
Pubmed	The myotubularin family: from genetic disease to phosphoinositide metabolism.	MTMR8 MTMR7	2.86e-05	3	108	2	11275328
Pubmed	Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2.	LATS1 LATS2	2.86e-05	3	108	2	24012335
Pubmed	Glucoamylase-like domains in the alpha- and beta-subunits of phosphorylase kinase.	PHKA1 PHKB	2.86e-05	3	108	2	12876330
Pubmed	Regulation of the atheroma-enriched protein, SPRR3, in vascular smooth muscle cells through cyclic strain is dependent on integrin alpha1beta1/collagen interaction.	SPRR3 ITGA1	2.86e-05	3	108	2	18832573
Pubmed	Assignment of human genes for phosphorylase kinase subunits alpha (PHKA) to Xq12-q13 and beta (PHKB) to 16q12-q13.	PHKA1 PHKB	2.86e-05	3	108	2	2757032
Pubmed	Mask family proteins ANKHD1 and ANKRD17 regulate YAP nuclear import and stability.	ANKHD1 ANKRD17	2.86e-05	3	108	2	31661072
Pubmed	Analysis of the large inactive P-TEFb complex indicates that it contains one 7SK molecule, a dimer of HEXIM1 or HEXIM2, and two P-TEFb molecules containing Cdk9 phosphorylated at threonine 186.	HEXIM1 HEXIM2	2.86e-05	3	108	2	15965233
Pubmed	Negative regulation of YAP by LATS1 underscores evolutionary conservation of the Drosophila Hippo pathway.	LATS1 LATS2	2.86e-05	3	108	2	18413746
Pubmed	Phosphorylase kinase: the complexity of its regulation is reflected in the complexity of its structure.	PHKA1 PHKB	2.86e-05	3	108	2	10487978
Pubmed	Identification of novel candidate genes for globin regulation in erythroid cells containing large deletions of the human beta-globin gene cluster.	ZHX2 ARID1B	2.86e-05	3	108	2	16952470
Pubmed	Tumor suppressor LATS1 is a negative regulator of oncogene YAP.	LATS1 LATS2	2.86e-05	3	108	2	18158288
Pubmed	LATS kinases and SLUG regulate the transition to advanced stage in aggressive oral cancer cells.	LATS1 LATS2	2.86e-05	3	108	2	35859006
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	ABCF3 HYOU1 COPA DSG1 TCOF1 SEC24A GRB2 LARP1 DARS1 ANKHD1 HEXIM1 TXNL1 MSH6 PRRC2C PALLD	3.23e-05	1415	108	15	28515276
Pubmed	PlexinA1 signaling directs the segregation of proprioceptive sensory axons in the developing spinal cord.	SEMA3G FZD8 SLITRK2 LRFN5 SDK1	3.34e-05	117	108	5	17145500
Pubmed	SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.	TET2 DSG1 TCOF1 ETV3 LARP1 DARS1 ANKHD1 MSH6 PRRC2C ANKRD17	3.88e-05	655	108	10	35819319
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	HEXA WDR70 MTMR8 RAP1GAP2 C15orf39 SPIRE1 ANKHD1 LATS2 PLA2G6 WDFY3 SUFU TOP3B MVB12B	3.96e-05	1105	108	13	35748872
Pubmed	The interactome of CLUH reveals its association to SPAG5 and its co-translational proximity to mitochondrial proteins.	UBAP2 TCOF1 LARP1 PHKA1 PRRC2C ANKRD17	4.29e-05	203	108	6	35012549
Pubmed	Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1.	LATS1 LATS2	5.71e-05	4	108	2	28754671
Pubmed	Targeted DNA Sequencing from Autism Spectrum Disorder Brains Implicates Multiple Genetic Mechanisms.	ARID1B SCN1A	5.71e-05	4	108	2	26637798
Pubmed	Gene fusion and overlapping reading frames in the mammalian genes for 4E-BP3 and MASK.	ANKHD1 ANKRD17	5.71e-05	4	108	2	14557257
Pubmed	RNA-driven cyclin-dependent kinase regulation: when CDK9/cyclin T subunits of P-TEFb meet their ribonucleoprotein partners.	HEXIM1 HEXIM2	5.71e-05	4	108	2	18655042
Pubmed	Inactivation of the Hippo tumor suppressor pathway promotes melanoma.	LATS1 LATS2	5.71e-05	4	108	2	35768444
Pubmed	Dorsal root ganglia isolated from Nf1+/- mice exhibit increased levels of mRNA expression of voltage-dependent sodium channels.	SCN1A SCN9A	5.71e-05	4	108	2	22260870
Pubmed	Isolation of cDNA clones for the catalytic gamma subunit of mouse muscle phosphorylase kinase: expression of mRNA in normal and mutant Phk mice.	PHKA1 PHKB	5.71e-05	4	108	2	3472241
Pubmed	Cytoplasmic ASPP1 inhibits apoptosis through the control of YAP.	LATS1 LATS2	5.71e-05	4	108	2	21041411
Pubmed	Hippo signalling maintains ER expression and ER+ breast cancer growth.	LATS1 LATS2	5.71e-05	4	108	2	33658690
Pubmed	Heat shock protein 90 inhibition depletes LATS1 and LATS2, two regulators of the mammalian hippo tumor suppressor pathway.	LATS1 LATS2	5.71e-05	4	108	2	20841485
Pubmed	WWC1 and NF2 Prevent the Development of Intrahepatic Cholangiocarcinoma by Regulating YAP/TAZ Activity through LATS in Mice.	LATS1 LATS2	5.71e-05	4	108	2	32451369
Pubmed	KIBRA regulates Hippo signaling activity via interactions with large tumor suppressor kinases.	LATS1 LATS2	5.71e-05	4	108	2	21233212
Pubmed	The tumor suppressor Lats2 is pivotal in Aurora A and Aurora B signaling during mitosis.	LATS1 LATS2	5.71e-05	4	108	2	21822051
Pubmed	Transcription-dependent association of multiple positive transcription elongation factor units to a HEXIM multimer.	HEXIM1 HEXIM2	5.71e-05	4	108	2	15994294
Pubmed	Phosphorylation of CHO1 by Lats1/2 regulates the centrosomal activation of LIMK1 during cytokinesis.	LATS1 LATS2	5.71e-05	4	108	2	25786116
Pubmed	RASSF1A-Mediated Suppression of Estrogen Receptor Alpha (ERα)-Driven Breast Cancer Cell Growth Depends on the Hippo-Kinases LATS1 and 2.	LATS1 LATS2	5.71e-05	4	108	2	34831091
Pubmed	Binding of Kif23-iso1/CHO1 to 14-3-3 is regulated by sequential phosphorylations at two LATS kinase consensus sites.	LATS1 LATS2	5.71e-05	4	108	2	25658096
Pubmed	Cleavage of phosphorylase kinase and calcium-free calmodulin by HIV-1 protease.	PHKA1 PHKB	5.71e-05	4	108	2	1872871
Pubmed	Hippo signaling instructs ectopic but not normal organ growth.	LATS1 LATS2	5.71e-05	4	108	2	36395225
Pubmed	Lats2/Kpm is required for embryonic development, proliferation control and genomic integrity.	LATS1 LATS2	5.71e-05	4	108	2	15343267
Pubmed	HEXIM2, a HEXIM1-related protein, regulates positive transcription elongation factor b through association with 7SK.	HEXIM1 HEXIM2	5.71e-05	4	108	2	15713662
Pubmed	Phosphorylase Kinase Deficiency	PHKA1 PHKB	5.71e-05	4	108	2	21634085
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	UBAP2 TCOF1 LATS1 EGR2 SCN1A UNK CAMTA1 SUFU	6.13e-05	430	108	8	35044719
Pubmed	Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS.	TCOF1 HEXIM1 HEXIM2 PHKA1 PRRC2C MAPKAPK3 MASTL WDFY3	6.33e-05	432	108	8	23455922
Pubmed	Hypertonicity-responsive ubiquitin ligase RNF183 promotes Na, K-ATPase lysosomal degradation through ubiquitination of its β1 subunit.	COPA TCOF1 SEC24A LARP1 ECPAS ANKHD1 TXNL1 ANKRD17	8.28e-05	449	108	8	31732153
Interaction	LRRC31 interactions	COPA LARP1 MED1 ECPAS PHKB MSH6 PRRC2C ANKRD17 TOP3B	1.48e-06	205	107	9	int:LRRC31
Interaction	MVB12B interactions	VPS37A SPPL3 TOP3B MVB12B	3.41e-06	20	107	4	int:MVB12B
Interaction	CNOT2 interactions	UBAP2 SPPL3 LARP1 ANKHD1 PRRC2C ANKRD17 UNK TOP3B	4.90e-06	178	107	8	int:CNOT2
Interaction	PLA2G6 interactions	SERTAD2 PLA2G6 TOP3B CCDC33	7.35e-06	24	107	4	int:PLA2G6
Interaction	NFIC interactions	TET2 ERG SEC24A BIRC2 HMG20A ARID1B LATS2 EGR2	1.64e-05	210	107	8	int:NFIC
Interaction	ZNF500 interactions	SPPL3 HEXIM2 TOP3B	1.70e-05	10	107	3	int:ZNF500
Interaction	GAREM2 interactions	GRB2 ECPAS TOP3B	2.33e-05	11	107	3	int:GAREM2
Interaction	ANKRD17 interactions	UBAP2 ECPAS ANKHD1 MSH6 PRRC2C ANKRD17 UNK TOP3B	2.78e-05	226	107	8	int:ANKRD17
Interaction	BICRA interactions	ERG SPPL3 ARID1B EGR2 TOP3B	2.85e-05	67	107	5	int:BICRA
Interaction	TBR1 interactions	NCOA2 TET2 HEXIM1 HMG20A ARID1B LATS1	3.10e-05	113	107	6	int:TBR1
Interaction	WWP2 interactions	UBAP2 TCOF1 NELFA GRB2 LARP1 DARS1 HEXIM1 ABRAXAS2 ARID1B LATS1 UBE2J2 EGR2 PRRC2C ANKRD17 PALLD	3.71e-05	840	107	15	int:WWP2
Interaction	ALG13 interactions	NCOA2 C15orf39 ARID1B LATS1 PRRC2C UNK WDFY3	5.51e-05	183	107	7	int:ALG13
Interaction	NAA40 interactions	UBAP2 DSG1 TCOF1 DLGAP5 WDR70 LARP1 DARS1 MED1 ANKHD1 CRACD MSH6 PRRC2C ATF7IP MASTL ANKRD17 PALLD	5.70e-05	978	107	16	int:NAA40
Interaction	NFIA interactions	NCOA2 ERG ETV3 TERF2IP HMG20A ARID1B EGR2	6.53e-05	188	107	7	int:NFIA
Interaction	QPRT interactions	ANKHD1 ARID1B PRRC2C ANKRD17 SUFU	8.50e-05	84	107	5	int:QPRT
Interaction	PIK3R3 interactions	SLC31A1 SPPL3 SERTAD2 GRB2 DARS1 WDFY3 CCDC33	9.04e-05	198	107	7	int:PIK3R3
Interaction	NCOA6 interactions	NCOA2 ERG MED1 TERF2IP EGR2 TOP3B	1.24e-04	145	107	6	int:NCOA6
Interaction	CPEB1 interactions	UBAP2 LARP1 ANKHD1 PRRC2C ANKRD17 UNK	1.29e-04	146	107	6	int:CPEB1
Interaction	SOX10 interactions	NCOA2 ERG HMG20A ARID1B EGR2	1.31e-04	92	107	5	int:SOX10
Interaction	RGMA interactions	NBEAL1 TERF2IP TOP3B	1.33e-04	19	107	3	int:RGMA
Interaction	ZNF263 interactions	ANKHD1 MSH6 ANKRD17 SUFU TOP3B ZNF445	1.44e-04	149	107	6	int:ZNF263
Interaction	ZC3H7A interactions	UBAP2 ANKHD1 PRRC2C UCP3 ANKRD17 UNK TOP3B	1.51e-04	215	107	7	int:ZC3H7A
Interaction	EGLN3 interactions	NCOA2 TET2 DENND4A UBAP2 COPA SEC24A DLGAP5 GRB2 C15orf39 BIRC2 ECPAS ANKHD1 NDUFB4 HEXIM1 MSH6 MASTL ANKRD17 SUFU	1.54e-04	1296	107	18	int:EGLN3
Interaction	LY6K interactions	SPPL3 LY6K	1.66e-04	4	107	2	int:LY6K
Interaction	ANKLE1 interactions	SPPL3 TOP3B	1.66e-04	4	107	2	int:ANKLE1
Interaction	ERG interactions	NCOA2 TET2 ERG C15orf39 HMG20A ARID1B ATF7IP	1.89e-04	223	107	7	int:ERG
Interaction	YWHAZ interactions	HEXA TET2 DENND4A NELFA SEC24A RAP1GAP2 GRB2 LARP1 SPIRE1 ZHX2 HEXIM1 CRACD LATS1 LATS2 UCP3 ANKRD17 UNK WDFY3	1.91e-04	1319	107	18	int:YWHAZ
Interaction	SOX6 interactions	NCOA2 ERG C15orf39 ZHX2 HMG20A PRRC2C	1.92e-04	157	107	6	int:SOX6
Interaction	DUSP5 interactions	SPPL3 ANKHD1 ANKRD17 TOP3B	2.08e-04	55	107	4	int:DUSP5
Interaction	ZNF341 interactions	SPPL3 GRB2 TOP3B	2.08e-04	22	107	3	int:ZNF341
GeneFamily	ESCRT-I	VPS37A MVB12B	5.84e-04	9	74	2	1116
GeneFamily	Sodium voltage-gated channel alpha subunits	SCN1A SCN9A	5.84e-04	9	74	2	1203
GeneFamily	WD repeat domain containing\|BEACH domain containing	NBEAL1 WDFY3	5.84e-04	9	74	2	1230
GeneFamily	Myotubularins\|Phosphoinositide phosphatases	MTMR8 MTMR7	1.68e-03	15	74	2	903
GeneFamily	Dyneins, axonemal	DNAH10 DNAH2	2.16e-03	17	74	2	536
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	KIRREL3 LRFN5 SDK1 PALLD	4.30e-03	161	74	4	593
GeneFamily	Guanylate cyclase receptors\|DENN/MADD domain containing	NPR2 DENND4A	4.66e-03	25	74	2	504
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Stem_cells-neuroepithelial-like_cells\|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.	NCOA2 NPR2 RAP1GAP2 ZHX2 LRFN5 MYO1F	6.79e-07	127	108	6	9071cd0953c8bb6746dc9cd13d153e3d6ef40b08
ToppCell	droplet-Heart-4Chambers-21m-Hematologic-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NPR2 TCOF1 DLGAP5 RAP1GAP2 WDFY3 TOP3B	3.83e-06	171	108	6	e852d0e8589eecf4a2e5fea039b52a67c5d58dbd
ToppCell	droplet-Heart-nan-3m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERG ITGA1 PKHD1L1 PRRC2C ATF7IP CDH11	6.21e-06	186	108	6	0ae5fbe9f210cb25092394267e1d3d6ed05627b8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ERG ITGA1 CRACD LRFN5 PALLD CDH11	7.01e-06	190	108	6	70c86dd454afb21d4a85db56c5f369d4b342bc97
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ERG ITGA1 CRACD LRFN5 PALLD CDH11	7.23e-06	191	108	6	107113b930d9ad171f1b2aa20df4567c94fae7d8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ERG ITGA1 CRACD LRFN5 PALLD CDH11	7.23e-06	191	108	6	bc353a79a1d11ca52bba5e3874a80d432e1a7715
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NCOA2 DENND4A ZHX2 ANKHD1 ARID1B ANKRD17	7.67e-06	193	108	6	779276e775cb2492e8dd36436295a536084a6415
ToppCell	COVID-19-kidney-Fibroblast-2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ITGA1 CRACD LRFN5 SDK1 PALLD CDH11	8.14e-06	195	108	6	3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	SERTAD2 RAP1GAP2 SLC12A5 PHKB ALOX15B	3.15e-05	149	108	5	a85a051e0d82430160967e72fa04b55f43e84513
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SERTAD2 RAP1GAP2 SLC12A5 PHKB ALOX15B	3.26e-05	150	108	5	7a381f5ae94eba5eb60dcbf83416b4eb18c279ea
ToppCell	367C-Lymphocytic-ILC-ILC-3\|367C / Donor, Lineage, Cell class and subclass (all cells)	ITGA1 ANKHD1 TERF2IP CD96 MVB12B	3.58e-05	153	108	5	9d64aadbb4bb28469af1d728457b431e21577429
ToppCell	COVID-CD8-memory_CD4\|COVID / Condition, Cell_class and T cell subcluster	ZNF793 NPR2 HEXIM1 PRR19 UNK	4.70e-05	162	108	5	22b2a32217d357146c117e618813d451510a1801
ToppCell	healthy_donor-Myeloid-Monocytic-Developing_Neutrophil\|healthy_donor / Disease condition, Lineage, Cell class and subclass	ERG DNAH10 ZNF670 DLGAP5 MMP8	5.91e-05	170	108	5	cfd7f29805b7c51666b0eaf269c36c96b8765a1a
ToppCell	T_cells-GNLY+GZMB+_T_cells\|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	ZNF670 RAP1GAP2 LILRB1 MYO1F PALLD	6.08e-05	171	108	5	04c811817cfec45af5f2891793106cc7ddb0300e
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC3-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NBEAL1 ETV3 C15orf39 PALLD ALOX15B	7.15e-05	177	108	5	d34b086a5931d7f1737a504952d51c47693e91a8
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERG NBEAL1 ITGA1 TTLL7 PRRC2C	7.35e-05	178	108	5	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_pre_proliferating_SCP_(4)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	SEMA3G TTLL7 KIRREL3 SLITRK2 SCN1A	8.16e-05	182	108	5	bfb725fff3d20066d8ac0a6ba2f88498fcbd876e
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 TTLL7 CRACD PALLD CDH11	8.37e-05	183	108	5	667717366cb181b8a04a347e64f0f5a4dfc6ee7f
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAH10 PKHD1L1 SLITRK2 SCN9A SDK1	8.59e-05	184	108	5	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 CRACD LRFN5 PALLD CDH11	8.59e-05	184	108	5	c5436a8e45f471b8d1301abbe9c7879204537f52
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAH10 PKHD1L1 SLITRK2 SCN9A SDK1	8.59e-05	184	108	5	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAH10 PKHD1L1 SLITRK2 SCN9A SDK1	8.59e-05	184	108	5	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DENND4A COPA SERTAD2 SPIRE1 ZHX2	8.81e-05	185	108	5	eb7d3c1363d5fedc611f9c1a91ea823de251355e
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	NCOA2 NBEAL1 ITGA1 MED1 CRACD	9.04e-05	186	108	5	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	COVID-19-Fibroblasts-Airway_smooth_muscle\|COVID-19 / group, cell type (main and fine annotations)	ITGA1 TTLL7 SDK1 PALLD CDH11	9.27e-05	187	108	5	464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell	COVID-19-kidney-Fibroblast-1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ITGA1 CRACD LRFN5 SDK1 CDH11	9.27e-05	187	108	5	76bfe8c42430a230a8bdf299575c444fb7780f24
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ITGA1 TERF2IP MYO1F CD96 MVB12B	9.27e-05	187	108	5	d17352f769c3c66601b65d060626eecff41b0482
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	ITGA1 CRACD LRFN5 PALLD CDH11	9.27e-05	187	108	5	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 CRACD LRFN5 PALLD CDH11	9.74e-05	189	108	5	71397e993a77d70b2eeede240bdfc7660b558987
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 CRACD LRFN5 PALLD CDH11	9.74e-05	189	108	5	4eea4759520c312bd17a681034d8074e47093d2b
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	ITGA1 LRFN5 SDK1 PALLD CDH11	9.99e-05	190	108	5	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 CRACD LRFN5 PALLD CDH11	1.02e-04	191	108	5	39092a0aff8097617820c59f5fea9ee2bb4f63a2
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ITGA1 LRFN5 SDK1 PALLD CDH11	1.02e-04	191	108	5	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 CRACD LRFN5 PALLD CDH11	1.02e-04	191	108	5	ee5f1b1c59029c46cbb1a00935c03b9317bb9da9
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 CRACD LRFN5 PALLD CDH11	1.05e-04	192	108	5	bc84b9ce01b4d826a682842ab8a395dac9b91183
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 CRACD LRFN5 PALLD CDH11	1.05e-04	192	108	5	0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DENND4A TCOF1 ZHX2 ARID1B ATF7IP	1.07e-04	193	108	5	bbea475d2c4c7b29674ff302529f8f83dd666dcb
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	ERG ITGA1 CRACD PALLD CDH11	1.07e-04	193	108	5	e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NPR2 ABCF3 C2CD4C HEXIM2 LRFN5	1.07e-04	193	108	5	e5016959f24370579a8770787e96869f264cf7b3
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	WDR70 SPPL3 ARID1B PRRC2C SDK1	1.07e-04	193	108	5	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	ITGA1 LRFN5 SDK1 PALLD CDH11	1.07e-04	193	108	5	acad568621ed677031797b8c2e34dafea798d681
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 CRACD LRFN5 PALLD CDH11	1.10e-04	194	108	5	81713e0409e8be695ba5dfdc67a997b33435dd9e
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	ITGA1 CRACD LRFN5 PALLD CDH11	1.10e-04	194	108	5	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 CRACD LRFN5 PALLD CDH11	1.10e-04	194	108	5	cf0244a29934e515446ac917d3c30672b460fb04
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ITGA1 TERF2IP ATF7IP CD96 MVB12B	1.10e-04	194	108	5	b0a7f5ca0c6f4f5764a8b35b5de80d82b828c66c
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ITGA1 LRFN5 SDK1 PALLD CDH11	1.10e-04	194	108	5	35f132cc38ac133be01834ed0946188aa0757eb4
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 CRACD LRFN5 PALLD CDH11	1.10e-04	194	108	5	ba7f971fb9a19423602da60770f23d9fead4a451
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ERG ITGA1 TTLL7 PALLD CDH11	1.10e-04	194	108	5	ebb038f94f49f5c655578d1b018676e10c6b7e3c
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 CRACD LRFN5 PALLD CDH11	1.10e-04	194	108	5	627cffe2d448e74fc5df92e74e5b922a73304137
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ERG ITGA1 CRACD PALLD CDH11	1.13e-04	195	108	5	49c99553629cdd83ee56a2e508d5bc8d34b8507b
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ERG ITGA1 CRACD PALLD CDH11	1.13e-04	195	108	5	dd281a249854800f737dc22e0f375f66dfb5cf5f
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	NCOA2 WDR70 ZHX2 ARID1B SDK1	1.16e-04	196	108	5	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	COVID-19-Myeloid-Monocytes\|COVID-19 / group, cell type (main and fine annotations)	TET2 RAP1GAP2 GRB2 LILRB1 MYO1F	1.16e-04	196	108	5	04d710267658ea5601ae2cfb4ed5acb8a29bd8a1
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ERG ITGA1 CRACD PALLD CDH11	1.16e-04	196	108	5	fa445f4240c521cf04eb2e2f79a5c55fda31209a
ToppCell	Children_(3_yrs)-Immune-monocyte\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TET2 RAP1GAP2 GRB2 LILRB1 MYO1F	1.16e-04	196	108	5	cacd69be72e6167814f7adea7c5fa114f3103bbb
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ERG ITGA1 CRACD PALLD CDH11	1.16e-04	196	108	5	802f61e78a9a1030a86c4a980c398a73cd4d1574
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ITGA1 TTLL7 MTMR7 LRFN5 PALLD	1.16e-04	196	108	5	9830fb3da7a60f65ad463e9054bb77c06b025e4d
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ITGA1 LRFN5 SDK1 PALLD CDH11	1.16e-04	196	108	5	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-skeletal_muscle_satellite_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TET2 SPIRE1 DARS1 EGR2 PRRC2C	1.18e-04	197	108	5	5bc11aff92da2a0aca8473f997fe7a99f3cae75d
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ERG ITGA1 LRFN5 PALLD CDH11	1.18e-04	197	108	5	85a8f1d18e0dd1d31341f5131eecd217553bf042
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ERG ITGA1 LRFN5 PALLD CDH11	1.18e-04	197	108	5	e8e3ba791dfaa0fab35e0329a5e34376f9ee6143
ToppCell	BAL-Mild-cDC_10\|Mild / Compartment, Disease Groups and Clusters	DENND4A SERTAD2 ETV3 PHKB CRACD	1.18e-04	197	108	5	c0550d41dd5619b369b590f3d6a61154dd7b2cab
ToppCell	distal-Hematologic-Nonclassical_Monocyte-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	RAP1GAP2 C15orf39 LILRB1 MAPKAPK3 MYO1F	1.18e-04	197	108	5	e817c1a8549e403e723b1b6c73cdb04f1179909d
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ERG ITGA1 LRFN5 PALLD CDH11	1.18e-04	197	108	5	9b480f9c799a244bfee64487abd8a1bf07c9a3a2
ToppCell	TCGA-Skin-Metastatic-Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	DENND4A NBEAL1 RBP5 LILRB1 MSH6	1.21e-04	198	108	5	af4fb9eb2295c7b90624b38ba25619aa15254efa
ToppCell	COVID-19_Mild\|World / Disease condition and Cell class	TET2 GRB2 LILRB1 PRRC2C MYO1F	1.21e-04	198	108	5	61ceb2245b6cb58e308b999a61d218c89dbc615e
ToppCell	TCGA-Skin-Metastatic\|TCGA-Skin / Sample_Type by Project: Shred V9	DENND4A NBEAL1 RBP5 LILRB1 MSH6	1.21e-04	198	108	5	ad39cce004867f083f8da1954e0cf5a263815184
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	DENND4A NBEAL1 RBP5 LILRB1 MSH6	1.21e-04	198	108	5	62cbf4b29e8af4983fb47a17f96da62682a5137e
ToppCell	nucseq-Mesenchymal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ITGA1 LRFN5 SDK1 PALLD CDH11	1.21e-04	198	108	5	8f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	NCOA2 WDR70 ZHX2 ARID1B WDFY3	1.24e-04	199	108	5	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Children_(3_yrs)-Immune-monocyte-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TET2 RAP1GAP2 GRB2 LILRB1 MYO1F	1.27e-04	200	108	5	881ab995c90d75fd987d6e8f1f926a4bfcc4235f
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ITGA1 LRFN5 SDK1 PALLD CDH11	1.27e-04	200	108	5	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW10-Mesenchymal\|GW10 / Sample Type, Dataset, Time_group, and Cell type.	DENND4A ERG ITGA1 SEMA3G EGR2	1.27e-04	200	108	5	5c638c80661017c85f9390f1b398ac7728c8f001
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ITGA1 LRFN5 SDK1 PALLD CDH11	1.27e-04	200	108	5	34f52003988ce6329d8deeee1ab875fa77e01e9d
Disease	Early Infantile Epileptic Encephalopathy 6	SCN1A SCN9A	1.33e-05	2	108	2	C4551549
Disease	Glycogen phosphorylase kinase deficiency	PHKA1 PHKB	7.93e-05	4	108	2	cv:C0268147
Disease	risk-taking behaviour	TET2 SLC12A5 MSH6 KIRREL3 ARID1B TTBK1 ABHD5 EGR2 LRFN5 SDK1 MVB12B	1.15e-04	764	108	11	EFO_0008579
Disease	centronuclear myopathy (implicated_via_orthology)	MTMR8 MTMR7	2.75e-04	7	108	2	DOID:14717 (implicated_via_orthology)
Disease	hematocrit	UBAP2 ERG NBEAL1 DNAH2 SERTAD2 HKDC1 SPIRE1 ITGA1 ABRAXAS2 ARID1B EGR2 ANKRD17	3.34e-04	1011	108	12	EFO_0004348
Disease	Early Childhood Epilepsy, Myoclonic	SCN1A SCN9A	3.66e-04	8	108	2	C0393695
Disease	Idiopathic Myoclonic Epilepsy	SCN1A SCN9A	3.66e-04	8	108	2	C0338478
Disease	Symptomatic Myoclonic Epilepsy	SCN1A SCN9A	3.66e-04	8	108	2	C0338479
Disease	Myoclonic Encephalopathy	SCN1A SCN9A	3.66e-04	8	108	2	C0438414
Disease	Ewings sarcoma	ERG EGR2	3.66e-04	8	108	2	C0553580
Disease	Benign Infantile Myoclonic Epilepsy	SCN1A SCN9A	3.66e-04	8	108	2	C0751120
Disease	benign neoplasm (implicated_via_orthology)	LATS1 LATS2	3.66e-04	8	108	2	DOID:0060072 (implicated_via_orthology)
Disease	Myoclonic Absence Epilepsy	SCN1A SCN9A	3.66e-04	8	108	2	C0393703
Disease	FEV change measurement, fatty liver disease	UBE2J2 CAMTA1	3.66e-04	8	108	2	EFO_0005921, MONDO_0004790
Disease	red blood cell density measurement	TET2 DENND4A ERG DNAH10 DNAH2 SERTAD2 ITGA1 HMG20A ARID1B PLA2G6 CAMTA1	3.88e-04	880	108	11	EFO_0007978
Disease	Febrile Convulsions	SLC12A5 SCN1A	4.70e-04	9	108	2	C0009952
Disease	Myoclonic Epilepsy	SCN1A SCN9A	4.70e-04	9	108	2	C0014550
Disease	centronuclear myopathy X-linked (implicated_via_orthology)	MTMR8 MTMR7	4.70e-04	9	108	2	DOID:0111225 (implicated_via_orthology)
Disease	Generalized Epilepsy with Febrile Seizures Plus	SCN1A SCN9A	4.70e-04	9	108	2	C3502809
Disease	vein graft stenosis	ARID1B PALLD	4.70e-04	9	108	2	EFO_0007051
Disease	Epilepsy, Myoclonic, Infantile	SCN1A SCN9A	5.86e-04	10	108	2	C0917800
Disease	generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology)	SCN1A SCN9A	5.86e-04	10	108	2	DOID:0111294 (implicated_via_orthology)
Disease	Dravet syndrome (implicated_via_orthology)	SCN1A SCN9A	5.86e-04	10	108	2	DOID:0080422 (implicated_via_orthology)
Disease	Epilepsy	SLC12A5 ARID1B SCN1A SCN9A	7.03e-04	109	108	4	C0014544
Disease	kidney cancer (implicated_via_orthology)	LATS1 LATS2	7.14e-04	11	108	2	DOID:263 (implicated_via_orthology)
Disease	Myoclonic Astatic Epilepsy	SCN1A SCN9A	7.14e-04	11	108	2	C0393702
Disease	generalized epilepsy with febrile seizures plus (implicated_via_orthology)	SCN1A SCN9A	8.55e-04	12	108	2	DOID:0060170 (implicated_via_orthology)
Disease	Infantile Severe Myoclonic Epilepsy	SCN1A SCN9A	1.01e-03	13	108	2	C0751122
Disease	leukemia	ERG BIRC2 MSH6	1.09e-03	55	108	3	C0023418
Disease	alkaline phosphatase measurement	NCOA2 TET2 SERTAD2 ITGA1 SLC12A5 PHKB KIRREL3 EGR2 ATF7IP ASL PLA2G6	1.25e-03	1015	108	11	EFO_0004533
Disease	cardiac troponin T measurement	NCOA2 NELFA UBE2J2 EGR2 SDK1	1.29e-03	219	108	5	EFO_0005043
Disease	reticulocyte count	DENND4A UBAP2 DNAH10 SPPL3 SERTAD2 LARP1 ITGA1 ZHX2 SLC12A5 MAPKAPK3 PLA2G6	1.57e-03	1045	108	11	EFO_0007986
Disease	Glycogen storage disease	PHKA1 PHKB	1.74e-03	17	108	2	cv:C0017919
Disease	level of Sphingomyelin (d38:2) in blood serum	MYO1F ANKRD17	2.18e-03	19	108	2	OBA_2045179
Disease	calcium measurement	TET2 VPS37A DNAH2 SEMA3G KIRREL3 MTMR7 ARID1B MVB12B	2.20e-03	628	108	8	EFO_0004838
Disease	prostate adenocarcinoma (is_implicated_in)	NCOA2 GRB2	2.42e-03	20	108	2	DOID:2526 (is_implicated_in)
Disease	triglyceride measurement, body fat percentage	DNAH10 PLA2G6	2.66e-03	21	108	2	EFO_0004530, EFO_0007800
Disease	colorectal carcinoma (is_implicated_in)	NCOA2 MSH6	2.92e-03	22	108	2	DOID:0080199 (is_implicated_in)
Disease	anxiety disorder (implicated_via_orthology)	SCN1A SCN9A	2.92e-03	22	108	2	DOID:2030 (implicated_via_orthology)
Disease	progranulin measurement	NCOA2 LRFN5	2.92e-03	22	108	2	EFO_0004625
Disease	taste liking measurement	TET2 OR10A3 KIRREL3 ARID1B CDH11 MVB12B	3.09e-03	388	108	6	EFO_0010155
Disease	Epilepsy, Cryptogenic	SLC12A5 ARID1B SCN1A	3.42e-03	82	108	3	C0086237
Disease	Awakening Epilepsy	SLC12A5 ARID1B SCN1A	3.42e-03	82	108	3	C0751111
Disease	Aura	SLC12A5 ARID1B SCN1A	3.42e-03	82	108	3	C0236018
Disease	Charcot-Marie-Tooth disease (implicated_via_orthology)	MTMR8 MTMR7	3.48e-03	24	108	2	DOID:10595 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
IFTQPFRMKQGSYST	TDRD5	216	Q8NAT2
TSTAYGVKKNMPQSP	COL17A1	301	Q9UMD9
TSPKTRPQNGSMILY	CAMTA1	96	Q9Y6Y1
MPRPQAVGSSNYAST	ABRAXAS2	331	Q15018
RQQGKPYTGFPMLSA	CCDC33	786	Q8N5R6
YGQTSKMSPRVPQQD	ERG	41	P11308
VMPNYPFINIRSSGV	ETV3	121	P41162
SMAKPRQDYSRTPGQ	MASTL	196	Q96GX5
AYSGSYPMAITPTQK	MASTL	686	Q96GX5
FTPKMQQQPTREFSG	ABCF3	316	Q9NUQ8
SSFPKRNSMTPNAPY	ARID1B	1316	Q8NFD5
PLPTTGMQKADVYSF	NPR2	696	P20594
NTAPTNATYPMPTAK	ANKRD17	2021	O75179
MSLPSVPKAQTSYGF	C2CD4C	136	Q8TF44
QRQFMEPGYPKSISG	MMP8	401	P22894
PGRYFLKSSPSTENM	DENND4A	1501	Q7Z401
PKNQYRSFMSQGSPE	NBEAL1	2331	Q6ZS30
PVSAPRNQTFTYMGK	EGR2	81	P11161
YRMIPPTSKTFLVNN	LRFN5	461	Q96NI6
NFVKNATSYPPMFTQ	CES1P1	76	Q9UKY3
VEGPRTPKYMNNITY	LARP1	371	Q6PKG0
NMTYLQPKSGYSPET	OR10A3	256	P58181
NDNTPMFTQPVYRVS	PCDHGA6	236	Q9Y5G7
PFYSNTGQAISPGMK	MAPKAPK3	241	Q16644
PPINSSVFKEYAGSM	LY6K	126	Q17RY6
KQRAPMYNSGLSPAT	NELFA	371	Q9H3P2
GKGSFPAMITPAYQR	NRAP	166	Q86VF7
RGKGSFPAMITPAYQ	NRAP	236	Q86VF7
RGKGSFPAMITPAYQ	NRAP	306	Q86VF7
RQMRPKTFPASNYTV	LATS1	11	O95835
IMQSSSKFNFPSGRP	LATS1	331	O95835
MRPKTFPATTYSGNS	LATS2	1	Q9NRM7
ANTPQDYSGNMKSFP	MTMR7	576	Q9Y216
KGFTMYGVLNPSTVP	MTMR8	476	Q96EF0
NAPKSPLTGYVRFMN	HMG20A	101	Q9NP66
MYLPTKLFQASRPSF	PHKA1	716	P46020
AYSTGSSLMPQKKNP	ASL	276	P04424
KGQPVAPYNTTQFLM	HEXIM1	196	O94992
VKYMTGTTVLPFNPA	ECPAS	576	Q5VYK3
KLSISFPNMTSNGYP	ITGA1	1001	P56199
MSRQSTLYSFFPKSP	MSH6	1	P52701
QTGMFPRNYVTPVNR	GRB2	201	P62993
VYPNFRPTPKNSLMG	NDUFB4	76	O95168
RPSTTVRYVMGNNPA	DSG1	416	Q02413
MGRTKQAPPQYTFIG	MVB12B	166	Q9H7P6
PAMQSSGSFNYARPK	PALLD	721	Q8WX93
RSGTASSVSYPKQMP	FZD8	676	Q9H461
SRMGPYPQRKVITFN	HYOU1	471	Q9Y4L1
QLRSGSKFPVFNMSY	COPA	356	P53621
QTMPRPYTFQVSSGG	CRACD	531	Q6ZU35
PKFPQSVYQMSVSEA	CDH11	266	P55287
KTYQVTPMTPRSANA	DLGAP5	321	Q15398
GLYSPSTNRGPIQMK	ATF7IP	896	Q6VMQ6
KQRVPTGMSFTNIYS	KIRREL3	666	Q8IZU9
QGPYTSMGKDNFVTP	LAS2	171	Q8IYD9
KSQVSIRYNSMPVPG	SLC31A1	96	O15431
ANPRYSPSVFGKAMV	DNAH10	3531	Q8IVF4
YNTVVQRFLPTPTKM	DNAH2	2596	Q9P225
FRMKQVNIVGPSPYS	SDK1	1146	Q7Z5N4
LRPQMASSKNYGSPL	MED1	1421	Q15648
MTSFYNTPPLGKRGT	PHKB	1051	Q93100
TKNVSMFPGNPERFS	SLC12A5	831	Q9H2X9
FTFPELMRKGSYNPV	HEXA	216	P06865
KPQFSAAPMTLLYQS	ALOX15B	306	O15296
MPPNLTGYYRFVSQK	RBP5	1	P82980
FNPVLYPKASQMIVS	RAP1GAP2	236	Q684P5
YMTPGLTPANSQASK	TCOF1	1206	Q13428
GKRHVQMESQFYPTP	HKDC1	101	Q2TB90
QKYQAEFPMGPVTSA	LILRB1	376	Q8NHL6
NPKMSRSVGYSYPSL	SEC24A	281	O95486
MFAKGQPVAPYNTTQ	HEXIM2	131	Q96MH2
SSSLQPYRSQPAFMQ	PRRC2C	2461	Q9Y520
PYRSQPAFMQSSLSQ	PRRC2C	2466	Q9Y520
RFMSANPSKVSYEPI	SCN9A	1866	Q15858
RQSFGPIMVYQTKSP	SLITRK2	321	Q9H156
FYTMPDPRNPKQSNS	DARS1	401	P14868
PNGYPIHSAMKFSQK	PLA2G6	251	O60733
YKSGTPMQSAAKAPY	PI4KAP2	256	A4QPH2
ERFMASNPSKVSYQP	SCN1A	1891	P35498
MSSYQQKQTFTPPPQ	SPRR3	1	Q9UBC9
TPSGETAFKNMTIPY	ABHD5	256	Q8WTS1
MHKTASQRLFPGPSY	BIRC2	1	Q13490
YQSLYMGNEPTPTKS	AKAP3	156	O75969
RMQPRGSFYSMVPNA	ANKHD1	2136	Q8IWZ3
TGPYPRNSKQAMSEG	C15orf39	231	Q6ZRI6
TTPQGSNYALKMNSP	NCOA2	456	Q15596
YTGTFAGQPVRFKMT	TOP3B	41	O95985
VKTRYMNSPPGQYFS	UCP3	241	P55916
QYGPTMFVPPASAKQ	UBAP2	926	Q5T6F2
AFTQNPALMYKPAVS	ZNF793	196	Q6ZN11
KPSNFAMGRLPSTYR	TTBK1	156	Q5TCY1
VFGNAPPNTMTEKFS	WDFY3	61	Q8IZQ1
PQPSNSSMTTRGFNY	CD96	431	P40200
QQGTKEFTFPMPYTS	PRR19	231	A6NJB7
YSSQPVTPSQPFKMD	SERTAD2	286	Q14140
GPANISGRMQKVSYF	SPPL3	301	Q8TCT6
RKTQSFYMSSPGPSE	SPIRE1	731	Q08AE8
SPAYSKTQPKTMFAQ	WDR70	621	Q9NW82
PSIYMITPNGRFKCN	UBE2J2	76	Q8N2K1
VSMYRNVGSPSANIP	SUFU	71	Q9UMX1
GRSFPQKMAYFVSSL	PKHD1L1	246	Q86WI1
TMINSFNKFPYPTQA	ZHX2	276	Q9Y6X8
NYRNMASLVGPFTKP	ZNF445	266	P59923
MTAQPGRPFGSTKDY	SEMA3G	386	Q9NS98
MSFPSSGRQSFYRNP	TPTE2	231	Q6XPS3
TSSVPGMNANALPFY	UNK	491	Q9C0B0
MPGGLPRQAYTQKTT	TET2	611	Q6N021
TPTYNLKYNSPGMTR	TTLL7	861	Q6ZT98
ASIPTSQNGFGYKMP	VPS37A	211	Q8NEZ2
GSSMSFYVRPSPAKR	TERF2IP	26	Q9NYB0
PSVFQMPQSTYTGEK	ZNF670	181	Q9BS34
APAFSSMSNKYPQAV	TXNL1	41	O43396
GSVLISVNPFKQMPY	MYO1F	51	O00160
SVNPFKQMPYFTDRE	MYO1F	56	O00160
SSRASPSQYMGPKRF	NAPEPLD	151	Q6IQ20